S-cystatin C vs.Injection Clearance Measurements to Estimate Kidney Function in Patients With Spinal Cord Injuries

Completed

• Conditions: Spinal Cord Injuries; Renal Failure

• Registration Number: NCT06565351
• Lead Sponsor: Rigshospitalet, Denmark

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-8-16
• Last Update Posted: 2 September 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Inclusion Criteria:<br><br>Neurogenic bladder dysfunction due to spinal cord injury<br><br>Exclusion Criteria:<br><br>None

Exclusion Criteria

Not provided

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Estimated clearance of Cystatin C (eGFR cystatin C)

Secondary Outcome Measures

Name	Time	Method
Test/ retest variability of eGFR cystatin C;Long term repeatability of eGFR cystatin C